Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Hazard Ratio (HR)
View:
Post by Noteable on Jun 05, 2023 8:16am

Hazard Ratio (HR)

The hazard ratio is the ratio of (chance of an event occurring in the treatment arm)/(chance of an event occurring in the control arm). The HR has also been defined as, the ratio of (risk of outcome in one group)/(risk of outcome in another group), occurring at a given interval of time 

A hazard ratio of 1 means lack of association, a hazard ratio greater than 1 suggests an increased risk (i.e disease progression or death ), and a hazard ratio below 1 suggests a smaller risk.
Comment by fox7mf on Jun 05, 2023 9:12am
Amazing success today. Those BP interested loved the hazard ratio of .29. I believe that I heard that right!!! Plus, MC confirmed they were very busy talking to potential suitors!!
Comment by Azzak34 on Jun 05, 2023 9:13am
Agree Foxy, big big step forward today. I bet they're clambering over themselves to do the phase 3. Amazing results. 
Comment by Noteable on Jun 05, 2023 10:53am
Bracelet-1 HR results of 0.29 in estrogen+/HER2 negative metastatic breast cancer disease reduction is particular compelling to Big Pharma  https://stockhouse.com/news/press-releases/2023/06/05/oncolytics-biotech-xae-announces-updated-randomized-phase-2-data-from-bracelet-1
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities